Related Experiment Video

Updated: Jan 19, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.9K

Possible immunotherapies of skin cancers

Zsuzsanna Lengyel1, Rolland Gyulai1

  • 1PTE KK, Bőr-, Nemikórtani és Onkodermatológiai Klinika, Pécs, Hungary

Magyar Onkologia
|September 21, 2019
PubMed

Insights

Skin cancers are rising globally, especially in the elderly. Immunotherapy, including PD-1 inhibitors, shows significant promise, with response rates over 40% for melanoma and other skin cancers.

Area of Science:

  • Oncology
  • Dermatology
  • Immunology

Background:

  • Skin cancers are the most common malignancies globally.
  • Incidence rates for melanoma and non-melanoma skin cancer are increasing worldwide, particularly in older populations.
  • Many skin cancer types demonstrate sensitivity to immunotherapy treatments.

Purpose of the Study:

  • To review current and emerging immunotherapy agents for skin cancer.
  • To discuss the efficacy of immunotherapy in treating various skin malignancies.
  • To provide an overview of future directions in skin cancer immunotherapy.

Main Methods:

  • Literature review of recent articles on immunotherapy for skin cancers.
  • Analysis of response rates for PD-1 inhibitor therapy in melanoma, Merkel cell carcinoma, and cutaneous squamous cell carcinoma.
  • Synthesis of information on current and future immunotherapy agents and procedures.

Main Results:

  • Melanoma, Merkel cell carcinoma, and cutaneous squamous cell carcinoma exhibit response rates of at least 40% to PD-1 inhibitor therapy.
  • Immunotherapy is a key treatment modality for a majority of skin cancer types.
  • The review covers a range of immunotherapy agents and procedural approaches.

Conclusions:

  • Immunotherapy represents a significant advancement in the treatment of skin cancers.
  • PD-1 inhibitor therapy offers substantial benefits for patients with specific skin malignancies.
  • Continued research into novel immunotherapy agents and strategies is crucial for improving patient outcomes in skin cancer.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
977
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K